HAL had a strong week. The stock gained nearly 7% to close at $41.81, recovering from the turbulence that marked most of April. The more interesting dynamic behind that move is what happened in the short book — and what a chorus of analyst upgrades says about the Street's revised view of the name.
The clearest narrative in positioning is a meaningful short unwind. Short interest in HAL fell roughly 9% over the past week, pulling the float-adjusted level down to 3.4% — having sat closer to 3.8% in the days immediately following the Q1 earnings release on April 21. That drop of around 11 million shares over the span of a few days is the most rapid compression in the 30-day window. The lending market reflects a stock that is easy to borrow: cost to borrow is running at just 0.45%, which while up around 15% over the week, remains close to historically low levels. Availability is wide and borrow conditions show no meaningful squeeze pressure whatsoever. Options positioning has ticked slightly more defensive — the put/call ratio at 0.79 is modestly above its 20-day average of 0.76, a z-score of roughly 1.2 — but that is a mild lean, not a directional call.
The Street's reaction to earnings was the week's loudest signal. Following the Q1 print, every major firm that weighed in raised its price target. JP Morgan lifted to $42 from $40 while keeping Overweight. Morgan Stanley matched that move from $40 to $42 on the same day. Citi went a step further, raising to $47 and reiterating Buy. RBC moved to $44. Even Barclays, which carries an Equal-Weight, pushed its target from $29 to $37 — a 27% increase, reflecting just how much the tariff-driven macro dislocation had pushed the prior target well below reality. Stifel raised its Buy target to $43 from $36. The consensus mean price target is $41.64, putting it essentially level with the current price. That tight alignment between current price and Street consensus means bulls are holding their ground rather than offering a large discount to entry. The bull case centres on HAL's dominant position in US completions and improving international mix; the bear case flags near-term weakness in North American stimulation activity and margin risk from reduced Middle East completion tool demand.
Factor scores are mixed but supportive. EPS surprise ranks in the 67th percentile, and the 12-month forward EPS year-on-year growth score checks in at the 65th percentile, meaning the earnings trajectory is holding up better than average across the universe. Dividend score ranks in the 85th percentile, though the dividend history in the snapshot is stale (last meaningful data from mid-2022) and should be treated with caution. The ORTEX short score of 32.8 is subdued and has eased further this week from 33.9 at the start — consistent with the covering pattern.
On the insider side, the recent trade log is uniformly negative. CEO Jeff Miller sold 158,455 shares at $40 in late March, a transaction worth over $6 million. The CFO, COO, and Chief Legal Officer all sold in early-to-mid March. Net 90-day insider value across all trades is a net sell of roughly $30 million. The sells came at prices between $33 and $40 — below where the stock trades today — which somewhat mutes their near-term informational value on direction, but the cluster of C-suite sales is worth tracking.
The most correlated peer, SLB, gained only 2.5% on the week versus HAL's 7%, suggesting HAL outperformed its closest comparator meaningfully. Smaller peers moved more dramatically — NBR was up over 20% and PTEN gained 14%, names that carry more leverage to any recovery in North American drilling activity. NOV added 5%.
The next data point to watch is any revision to the broader US drilling and completions activity outlook — HAL's relative outperformance this week has reset the stock back near analyst consensus, leaving little margin for disappointment in the cycle.
See the live data behind this article on ORTEX.
Open HAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
